{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T20:45:36Z","timestamp":1787949936901,"version":"build-2784847793"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No. 72104044"],"award-info":[{"award-number":["No. 72104044"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100005047","name":"Natural Science Foundation of Liaoning Province","doi-asserted-by":"publisher","award":["No. 2024-MSLH-106"],"award-info":[{"award-number":["No. 2024-MSLH-106"]}],"id":[{"id":"10.13039\/501100005047","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Psoriasis-associated dyslipidemia presents as a critical comorbidity characterized by a self-perpetuating cycle of metabolic dysfunction and chronic inflammation. Current treatment paradigms lack the capacity to simultaneously modulate these interconnected pathological axes. Here we investigated the efficacy and mechanisms of brusatol (a natural quassinoid derived from Bruceae Fructus) against psoriatic dyslipidemia from the insight of restoring lipid homeostasis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The in vitro efficacy of brusatol was assessed in TNF-\u03b1-stimulated HaCaT keratinocytes by evaluating proliferation, apoptosis, and inflammatory responses. In vivo, its therapeutic activity and systemic toxicity were examined in an imiquimod-induced psoriatic mouse model using PASI scoring, histopathological analysis, serum biochemical markers (TC, TG, ALT, AST, Cre), inflammatory cytokines (TNF-\u03b1, IL-1\u03b2, IL-17A), and BBB-chip analysis. Integrated proteomics and lipidomics of skin tissue and serum revealed dysregulated pathways, and subsequent target engagement was confirmed via molecular docking, CETSA, and DARTS. Mechanistic investigations included IL-1\u03b2 overexpression, Co-IP, GST pull-down and AMPK pathway analysis (Western blot, qPCR) was explored to delineate the regulatory mechanisms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Brusatol dose-dependently suppresses proliferation and inflammatory mediator expression in TNF-\u03b1-induced HaCaT keratinocytes, ameliorates skin lesions and systemic dyslipidemia in mice, effectively normalizing serum TC and TG levels without inducing visceral organ toxicity. Further integrated omic analyses and subsequent target validation identified IL-1\u03b2 as the direct target linking inflammatory signaling and lipid dysregulation. Mechanistic studies uncovered a novel IL-1\u03b2\u2013AMPK physical interaction that sequesters AMPK in the cytoplasm. Brusatol disrupts this complex, facilitating AMPK nuclear translocation to suppress lipogenic regulators (SREBP-1c\/FASN\/ACC1) and potentiate \u03b2-oxidation pathways (PPAR\u03b1\/CPT1A), thereby restoring lipid homeostasis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our findings not only establish brusatol as an effective agent for ameliorating psoriatic dyslipidemia, but also unveil a fundamental IL-1\u03b2\u2013AMPK interaction that orchestrates inflammation-metabolism crosstalk.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13020-025-01287-8","type":"journal-article","created":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T05:02:17Z","timestamp":1767848537000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Brusatol ameliorates psoriatic dyslipidemia by targeting IL-1\u03b2 to restore AMPK-mediated lipid homeostasis"],"prefix":"10.1186","volume":"21","author":[{"given":"Yuankuan","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shumeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hewen","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kejia","family":"lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinchao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renchuan","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiujie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shurong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialin","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingrong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,8]]},"reference":[{"issue":"2","key":"1287_CR1","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/jid.2012.339","volume":"133","author":"R Parisi","year":"2013","unstructured":"Parisi R, Symmons DP, Griffiths CE, Ashcroft DM. Global epidemiology of psoriasis: a systematic review of incidence and prevalence. J Invest Dermatol. 2013;133(2):377\u201385.","journal-title":"J Invest Dermatol"},{"key":"1287_CR2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m1590","volume":"369","author":"R Parisi","year":"2020","unstructured":"Parisi R, Iskandar IYK, Kontopantelis E, Augustin M, Griffiths CEM, Ashcroft DM. National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study. BMJ. 2020;369:m1590.","journal-title":"BMJ"},{"issue":"6","key":"1287_CR3","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1684\/ejd.2024.4800","volume":"34","author":"S Zhenfu","year":"2024","unstructured":"Zhenfu S, Wenting S, Xi W, Shiyu T, Zhenlin C. Metabolic syndrome and the risk of psoriasis: a population-based cross-sectional study and Mendelian randomization analysis. Eur J Dermatol. 2024;34(6):632\u20139.","journal-title":"Eur J Dermatol"},{"issue":"4","key":"1287_CR4","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.jaad.2012.08.015","volume":"68","author":"AW Armstrong","year":"2013","unstructured":"Armstrong AW, Harskamp CT, Armstrong EJ. Psoriasis and metabolic syndrome: a systematic review and meta-analysis of observational studies. J Am Acad Dermatol. 2013;68(4):654\u201362.","journal-title":"J Am Acad Dermatol"},{"issue":"19","key":"1287_CR5","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1001\/jama.2020.4006","volume":"323","author":"AW Armstrong","year":"2020","unstructured":"Armstrong AW, Read C. Pathophysiology, clinical presentation, and treatment of psoriasis: a review. JAMA. 2020;323(19):1945\u201360.","journal-title":"JAMA"},{"issue":"4","key":"1287_CR6","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s40257-024-00857-0","volume":"25","author":"F Bellinato","year":"2024","unstructured":"Bellinato F, Maurelli M, Geat D, Girolomoni G, Gisondi P. Managing the patient with psoriasis and metabolic comorbidities. Am J Clin Dermatol. 2024;25(4):527\u201340.","journal-title":"Am J Clin Dermatol"},{"issue":"6","key":"1287_CR7","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1007\/s12272-014-0496-0","volume":"38","author":"NM Kulkarni","year":"2015","unstructured":"Kulkarni NM, Muley MM, Jaji MS, Vijaykanth G, Raghul J, Reddy NK, et al. Topical atorvastatin ameliorates 12-O-tetradecanoylphorbol-13-acetate induced skin inflammation by reducing cutaneous cytokine levels and NF-\u03baB activation. Arch Pharm Res. 2015;38(6):1238\u201347.","journal-title":"Arch Pharm Res"},{"issue":"4","key":"1287_CR8","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/cmi.2012.15","volume":"9","author":"Y Cai","year":"2012","unstructured":"Cai Y, Fleming C, Yan J. New insights of T cells in the pathogenesis of psoriasis. Cell Mol Immunol. 2012;9(4):302\u20139.","journal-title":"Cell Mol Immunol"},{"issue":"6","key":"1287_CR9","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.2337\/db10-1278","volume":"60","author":"FC McGillicuddy","year":"2011","unstructured":"McGillicuddy FC, Harford KA, Reynolds CM, Oliver E, Claessens M, Mills KH, et al. Lack of interleukin-1 receptor I (IL-1RI) protects mice from high-fat diet-induced adipose tissue inflammation coincident with improved glucose homeostasis. Diabetes. 2011;60(6):1688\u201398.","journal-title":"Diabetes"},{"issue":"11","key":"1287_CR10","first-page":"12626","volume":"13","author":"H Shen","year":"2021","unstructured":"Shen H, Sha Y, Huang J, Mao AQ, Zhang T, Wu MY, et al. The roles of AMPK-mediated autophagy and mitochondrial autophagy in a mouse model of imiquimod-induced psoriasis. Am J Transl Res. 2021;13(11):12626\u201337.","journal-title":"Am J Transl Res"},{"issue":"4","key":"1287_CR11","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.cmet.2011.03.009","volume":"13","author":"Y Li","year":"2011","unstructured":"Li Y, Xu S, Mihaylova MM, Zheng B, Hou X, Jiang B, et al. AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice. Cell Metab. 2011;13(4):376\u201388.","journal-title":"Cell Metab"},{"issue":"12","key":"1287_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.4358","volume":"32","author":"N Guo","year":"2018","unstructured":"Guo N, Xu X, Yuan G, Chen X, Wen Q, Guo R. Pharmacokinetic, metabolic profiling and elimination of brusatol in rats. Biomedical Chromatogr. 2018;32(12):e4358.","journal-title":"Biomedical Chromatogr"},{"key":"1287_CR13","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.jchromb.2017.04.012","volume":"1053","author":"N Guo","year":"2017","unstructured":"Guo N, Zhang X, Bu F, Wang L, Cao Z, Geng C, et al. Determination of brusatol in plasma and tissues by LC-MS method and its application to a pharmacokinetic and distribution study in mice. J Chromatogr B Analyt Technol Biomed Life Sci. 2017;1053:20\u20136.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"1287_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2024.116197","volume":"223","author":"X Li","year":"2024","unstructured":"Li X, Jiang Y, Wang Y, Li N, Zhang S, Lv K, et al. KLF4 suppresses anticancer effects of brusatol via transcriptional upregulating NCK2 expression in melanoma. Biochem Pharmacol. 2024;223:116197.","journal-title":"Biochem Pharmacol"},{"key":"1287_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2025.114482","volume":"153","author":"Y Xu","year":"2025","unstructured":"Xu Y, Chen L, Hu X, Lai Z, Chen B, Wu M, et al. Brusatol ameliorates intestinal mucosal injury in ulcerative colitis via activating IL-22\/STAT3 pathway. Int Immunopharmacol. 2025;153:114482.","journal-title":"Int Immunopharmacol"},{"key":"1287_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.108851","volume":"108","author":"A Donato-Trancoso","year":"2022","unstructured":"Donato-Trancoso A, Correa Atella G, Romana-Souza B. Dietary olive oil intake aggravates psoriatic skin inflammation in mice via Nrf2 activation and polyunsaturated fatty acid imbalance. Int Immunopharmacol. 2022;108:108851.","journal-title":"Int Immunopharmacol"},{"key":"1287_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2023.108411","volume":"245","author":"T Kanno","year":"2023","unstructured":"Kanno T, Nakajima T, Miyako K, Endo Y. Lipid metabolism in Th17 cell function. Pharmacol Ther. 2023;245:108411.","journal-title":"Pharmacol Ther"},{"key":"1287_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22126561","author":"J Nowowiejska","year":"2021","unstructured":"Nowowiejska J, Baran A, Flisiak I. Aberrations in lipid expression and metabolism in psoriasis. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms22126561.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"1287_CR19","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.bbalip.2017.02.005","volume":"1862","author":"E Makoveichuk","year":"2017","unstructured":"Makoveichuk E, Vorrsj\u00f6 E, Olivecrona T, Olivecrona G. TNF-\u03b1 decreases lipoprotein lipase activity in 3T3-L1 adipocytes by up-regulation of angiopoietin-like protein 4. Biochimica et Biophysica Acta (BBA). 2017;1862(5):533\u201340.","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"issue":"4","key":"1287_CR20","doi-asserted-by":"publisher","first-page":"573","DOI":"10.3892\/br.2013.126","volume":"1","author":"MS Daoud","year":"2013","unstructured":"Daoud MS, Ataya FS, Fouad D, Alhazzani A, Shehata AI, Al-Jafari AA. Associations of three lipoprotein lipase gene polymorphisms, lipid profiles and coronary artery disease. Biomed Rep. 2013;1(4):573\u201382.","journal-title":"Biomed Rep"},{"key":"1287_CR21","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.addr.2020.06.028","volume":"159","author":"A Leuti","year":"2020","unstructured":"Leuti A, Fazio D, Fava M, Piccoli A, Oddi S, Maccarrone M. Bioactive lipids, inflammation and chronic diseases. Adv Drug Deliv Rev. 2020;159:133\u201369.","journal-title":"Adv Drug Deliv Rev"},{"issue":"19","key":"1287_CR22","doi-asserted-by":"publisher","first-page":"2978","DOI":"10.1002\/1873-3468.12702","volume":"591","author":"IG Schulman","year":"2017","unstructured":"Schulman IG. Liver X receptors link lipid metabolism and inflammation. FEBS Lett. 2017;591(19):2978\u201391.","journal-title":"FEBS Lett"},{"key":"1287_CR23","doi-asserted-by":"publisher","first-page":"1124786","DOI":"10.3389\/fimmu.2023.1124786","volume":"14","author":"L Luo","year":"2023","unstructured":"Luo L, Guo Y, Chen L, Zhu J, Li C. Crosstalk between cholesterol metabolism and psoriatic inflammation. Front Immunol. 2023;14:1124786.","journal-title":"Front Immunol"},{"issue":"4","key":"1287_CR24","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1007\/s11010-021-04061-0","volume":"476","author":"B Khwaja","year":"2021","unstructured":"Khwaja B, Thankam FG, Agrawal DK. Mitochondrial DAMPs and altered mitochondrial dynamics in OxLDL burden in atherosclerosis. Mol Cell Biochem. 2021;476(4):1915\u201328.","journal-title":"Mol Cell Biochem"},{"issue":"8","key":"1287_CR25","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1136\/gutjnl-2024-334010","volume":"74","author":"F Kou","year":"2025","unstructured":"Kou F, Li XY, Feng Z, Hua J, Wu X, Gao H, et al. GPR171 restrains intestinal inflammation by suppressing FABP5-mediated Th17 cell differentiation and lipid metabolism. Gut. 2025;74(8):1279\u201392.","journal-title":"Gut"},{"key":"1287_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13092691","author":"M Megna","year":"2024","unstructured":"Megna M, Ruggiero A, Martora F, Vallone Y, Guerrasio G, Potestio L. Long-term efficacy and safety of guselkumab in psoriasis patients who failed anti-IL17: a two-year real-life study. J Clin Med. 2024. https:\/\/doi.org\/10.3390\/jcm13092691.","journal-title":"J Clin Med"},{"issue":"10","key":"1287_CR27","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15760","volume":"35","author":"R Ruiz-Villaverde","year":"2022","unstructured":"Ruiz-Villaverde R, Rodriguez-Fernandez-Freire L, Armario-Hita JC, P\u00e9rez-Gil A, Chinchay FV, Gal\u00e1n-Guti\u00e9rrez M. Guselkumab as a switching strategy after anti-TNF\u03b1, anti-IL17, or anti-IL12\/23 therapies in moderate-to-severe psoriasis. Dermatol Ther. 2022;35(10):e15760.","journal-title":"Dermatol Ther"},{"issue":"4","key":"1287_CR28","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1097\/CAD.0000000000001022","volume":"32","author":"H Chen","year":"2021","unstructured":"Chen H, Jiang T, Chen H, Su J, Wang X, Cao Y, et al. Brusatol reverses lipopolysaccharide-induced epithelial-mesenchymal transformation and induces apoptosis through PI3K\/Akt\/NF-\u03baB pathway in human gastric cancer SGC-7901 cells. Anticancer Drugs. 2021;32(4):394\u2013404.","journal-title":"Anticancer Drugs"},{"key":"1287_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2025.156464","volume":"139","author":"X Yuan","year":"2025","unstructured":"Yuan X, Yu S, Lin L, Chen Y, Wu Z, Fang X, et al. Brusatol inhibits malignant phenotypes and lipid metabolism of osteosarcoma cells by regulating PI3K\/AKT and MAPK pathways. Phytomedicine. 2025;139:156464.","journal-title":"Phytomedicine"},{"issue":"3","key":"1287_CR30","doi-asserted-by":"publisher","DOI":"10.1111\/cns.14456","volume":"30","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Ye P, Zhu H, Gu L, Li Y, Feng S, et al. Neutral polysaccharide from Gastrodia elata alleviates cerebral ischemia-reperfusion injury by inhibiting ferroptosis-mediated neuroinflammation via the NRF2\/HO-1 signaling pathway. CNS Neurosci Ther. 2024;30(3):e14456.","journal-title":"CNS Neurosci Ther"},{"key":"1287_CR31","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.jare.2020.07.011","volume":"34","author":"H Xu","year":"2021","unstructured":"Xu H, Shen J, Xiao J, Chen F, Wang M. Neuroprotective effect of cajaninstilbene acid against cerebral ischemia and reperfusion damages by activating AMPK\/Nrf2 pathway. J Adv Res. 2021;34:199\u2013210.","journal-title":"J Adv Res"},{"key":"1287_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.714897","volume":"12","author":"S Mizuguchi","year":"2021","unstructured":"Mizuguchi S, Gotoh K, Nakashima Y, Setoyama D, Takata Y, Ohga S, et al. Mitochondrial reactive oxygen species are essential for the development of psoriatic inflammation. Front Immunol. 2021;12:714897.","journal-title":"Front Immunol"},{"issue":"1","key":"1287_CR33","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.jid.2018.07.025","volume":"139","author":"Y Cai","year":"2019","unstructured":"Cai Y, Xue F, Quan C, Qu M, Liu N, Zhang Y, et al. A critical role of the IL-1\u03b2-IL-1R signaling pathway in skin inflammation and psoriasis pathogenesis. J Invest Dermatol. 2019;139(1):146\u201356.","journal-title":"J Invest Dermatol"},{"issue":"2","key":"1287_CR34","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/S1097-2765(02)00599-3","volume":"10","author":"F Martinon","year":"2002","unstructured":"Martinon F, Burns K, Tschopp J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell. 2002;10(2):417\u201326.","journal-title":"Mol Cell"},{"issue":"2","key":"1287_CR35","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.immuni.2009.08.001","volume":"31","author":"CE Sutton","year":"2009","unstructured":"Sutton CE, Lalor SJ, Sweeney CM, Brereton CF, Lavelle EC, Mills KH. Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity. Immunity. 2009;31(2):331\u201341.","journal-title":"Immunity"},{"issue":"6","key":"1287_CR36","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/j.immuni.2015.12.003","volume":"43","author":"DD Patel","year":"2015","unstructured":"Patel DD, Kuchroo VK. Th17 cell pathway in human immunity: lessons from genetics and therapeutic interventions. Immunity. 2015;43(6):1040\u201351.","journal-title":"Immunity"},{"issue":"1","key":"1287_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-51938-x","volume":"15","author":"K Hofwimmer","year":"2024","unstructured":"Hofwimmer K, de Paula Souza J, Subramanian N, Vuji\u010di\u0107 M, Rachid L, M\u00e9reau H, et al. IL-1\u03b2 promotes adipogenesis by directly targeting adipocyte precursors. Nat Commun. 2024;15(1):7957.","journal-title":"Nat Commun"},{"issue":"6","key":"1287_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112647","volume":"42","author":"L Sun","year":"2023","unstructured":"Sun L, Zhang X, Wu S, Liu Y, Guerrero-Juarez CF, Liu W, et al. Dynamic interplay between IL-1 and WNT pathways in regulating dermal adipocyte lineage cells during skin development and wound regeneration. Cell Rep. 2023;42(6):112647.","journal-title":"Cell Rep"},{"issue":"6","key":"1287_CR39","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.cmet.2010.11.011","volume":"12","author":"R Stienstra","year":"2010","unstructured":"Stienstra R, Joosten LA, Koenen T, van Tits B, van Diepen JA, van den Berg SA, et al. The inflammasome-mediated caspase-1 activation controls adipocyte differentiation and insulin sensitivity. Cell Metab. 2010;12(6):593\u2013605.","journal-title":"Cell Metab"},{"issue":"2","key":"1287_CR40","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1530\/JOE-12-0565","volume":"217","author":"A Gagnon","year":"2013","unstructured":"Gagnon A, Foster C, Landry A, Sorisky A. The role of interleukin 1\u03b2 in the anti-adipogenic action of macrophages on human preadipocytes. J Endocrinol. 2013;217(2):197\u2013206.","journal-title":"J Endocrinol"},{"issue":"4","key":"1287_CR41","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nrm3311","volume":"13","author":"DG Hardie","year":"2012","unstructured":"Hardie DG, Ross FA, Hawley SA. AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat Rev Mol Cell Biol. 2012;13(4):251\u201362.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1287_CR42","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.freeradbiomed.2025.06.016","volume":"237","author":"A Li","year":"2025","unstructured":"Li A, Zhuang Z, Xia Q, Zhou X, Yang J, Liu B, et al. P67phox\/NOX2 inhibits psoriasis by regulating the HIF-1\u03b1-glycolysis axis via p53-AMPK in keratinocytes. Free Radic Biol Med. 2025;237:503\u201314.","journal-title":"Free Radic Biol Med"},{"issue":"2","key":"1287_CR43","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/ncb2152","volume":"13","author":"J Kim","year":"2011","unstructured":"Kim J, Kundu M, Viollet B, Guan KL. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol. 2011;13(2):132\u201341.","journal-title":"Nat Cell Biol"},{"issue":"6016","key":"1287_CR44","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1126\/science.1196371","volume":"331","author":"DF Egan","year":"2011","unstructured":"Egan DF, Shackelford DB, Mihaylova MM, Gelino S, Kohnz RA, Mair W, et al. Phosphorylation of ULK1 (hATG1) by AMP-activated protein kinase connects energy sensing to mitophagy. Science. 2011;331(6016):456\u201361.","journal-title":"Science"},{"key":"1287_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24032112","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Wu F, Teng F, Guo S, Li H. Deficiency of S100A9 alleviates sepsis-induced acute liver injury through regulating AKT-AMPK-dependent mitochondrial energy metabolism. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms24032112.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1287_CR46","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1038\/s41467-025-57044-w","volume":"16","author":"C Peng","year":"2025","unstructured":"Peng C, Jiang H, Jing L, Yang W, Guan X, Wang H, et al. Macrophage SUCLA2 coupled glutaminolysis manipulates obesity through AMPK. Nat Commun. 2025;16(1):1738.","journal-title":"Nat Commun"},{"key":"1287_CR47","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.mce.2016.11.010","volume":"440","author":"SJ Mancini","year":"2017","unstructured":"Mancini SJ, White AD, Bijland S, Rutherford C, Graham D, Richter EA, et al. Activation of AMP-activated protein kinase rapidly suppresses multiple pro-inflammatory pathways in adipocytes including IL-1 receptor-associated kinase-4 phosphorylation. Mol Cell Endocrinol. 2017;440:44\u201356.","journal-title":"Mol Cell Endocrinol"},{"issue":"4878","key":"1287_CR48","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1126\/science.3140380","volume":"242","author":"PA Baeuerle","year":"1988","unstructured":"Baeuerle PA, Baltimore D. I kappa B: a specific inhibitor of the NF-kappa B transcription factor. Science. 1988;242(4878):540\u20136.","journal-title":"Science"},{"issue":"2","key":"1287_CR49","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/0092-8674(90)90806-P","volume":"61","author":"U Zabel","year":"1990","unstructured":"Zabel U, Baeuerle PA. Purified human I kappa B can rapidly dissociate the complex of the NF-kappa B transcription factor with its cognate DNA. Cell. 1990;61(2):255\u201365.","journal-title":"Cell"}],"updated-by":[{"DOI":"10.1186\/s13020-026-01493-y","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000}}],"container-title":["Chinese Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-025-01287-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13020-025-01287-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-025-01287-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T08:38:08Z","timestamp":1787906288000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13020-025-01287-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,8]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1287"],"URL":"https:\/\/doi.org\/10.1186\/s13020-025-01287-8","relation":{},"ISSN":["1749-8546"],"issn-type":[{"value":"1749-8546","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,8]]},"assertion":[{"value":"19 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s13020-026-01493-y","URL":"https:\/\/doi.org\/10.1186\/s13020-026-01493-y","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Jialin Qu serves as a member of the Youth Editorial Board of Chinese Medicine. The author was not involved in the review or decision-making process for this manuscript. The authors declare no other conflicts of interest.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"18"}}